BioNTech-Fosun mRNA新冠肺炎疫苗抵达北京，适用于居住在中国的德国公民 - BioNTech-Fosun mRNA COVID-19 vaccine arrives in Beijin
据新闻网站Thepaper周四报道，由德国BioNTech公司和中国复星制药公司联合开发的约11500剂新冠肺炎mRNA疫苗已抵达北京，预计将在北京、上海、广州、沈阳和成都为居住在中国的德国国民提供疫苗接种，新冠肺炎mRNA疫苗于周三抵达中国大陆，其中含有两家公司的Omicron BA.4/BA.5自适应二价新冠肺炎疫苗
0评论2022-12-23599
Study by Pfizer/BioNtech finds its COVID-19 vaccine 73.2 pct efficient in children
The COVID-19 vaccine from BioNTech and Pfizer provides 73.2 percent protection for young children aged six months to four years, according t
0评论2022-08-24673
